Peter Karczmar MD in Providence, Rhode Island

Additional Medical Specialties Include:
SLEEP MEDICINE

Medical School: Rutgers New Jersey Medical School
Graduation Year: 1986
The Primary Medical Specialty for Peter Karczmar MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 38
PAC (PECOS ID)#: 5092762351
NPI #: 1124015813
NPI Created On: 09/29/2005
NPI Last Updated Listed as: 01/03/2023
Primary Taxonomy Code: 207RS0012X
License Number:
MD07447
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Harvard Pilgrim Health Care Inc.
• Medicare

They are listed as accepting new patients.

---

Services and Procedures include:

1. Vaccine for influenza for injection into muscle
2. Measurement and graphic recording of total and timed exhaled air capacity
3. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
4. Multiple measurements and graphic recordings of the amount and speed of breathed air, before and following medication administration
5. Test for exercise-induced lung stress
6. Determination of lung volumes using plethysmography
7. Measurement of lung diffusing capacity
8. Inhalation of medications with allergic reaction analysis
9. New patient office or other outpatient visit, typically 30 minutes
10. New patient office or other outpatient visit, typically 45 minutes
11. Established patient office or other outpatient visit, typically 15 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Initial hospital inpatient care, typically 50 minutes per day
14. Subsequent hospital inpatient care, typically 25 minutes per day
15. Physician telephone patient service, 5-10 minutes of medical discussion
16. Physician telephone patient service, 11-20 minutes of medical discussion
17. Physician telephone patient service, 21-30 minutes of medical discussion
18. Administration of influenza virus vaccine
19. Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation
20. Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).